Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.

MLA

Chikh, Ghania, et al. “Synthetic Methylated CpG ODNs Are Potent in Vivo Adjuvants When Delivered in Liposomal Nanoparticles.” International Immunology, vol. 21, no. 7, July 2009, pp. 757–67. EBSCOhost, https://doi.org/10.1093/intimm/dxp044.

APA

Chikh, G., de Jong, S. D., Sekirov, L., Raney, S. G., Kazem, M., Wilson, K. D., Cullis, P. R., Dutz, J. P., & Tam, Y. K. (2009). Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. International Immunology, 21(7), 757–767. https://doi.org/10.1093/intimm/dxp044

Chicago

Chikh, Ghania, Susan D de Jong, Laura Sekirov, Sameersingh G Raney, Mikameh Kazem, Kaley D Wilson, Pieter R Cullis, Jan P Dutz, and Ying K Tam. 2009. “Synthetic Methylated CpG ODNs Are Potent in Vivo Adjuvants When Delivered in Liposomal Nanoparticles.” International Immunology 21 (7): 757–67. doi:10.1093/intimm/dxp044.